EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pericyte phenotype switching in cancer

Bo He, Ruth Ganss

Trends in Cancer · 2025-09 · 11 (9) · 877-888

DOI: 10.1016/j.trecan.2025.06.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Cancer, 2025-09. Verfasst von Bo He und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University …. Hauptthemen laut MEDLINE: Pericytes, Neoplasms, Neovascularization, Pathologic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: Cancer Australia, Cancer Council Western Australia, Eisai Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pericytes play an important physiological role as guardians of vascular integrity. In cancer, however, pericytes undergo profound phenotypic changes which foster tumor progression. Emerging transcriptomics and functional data provide evidence for a shift from quiescent to highly proliferating, matrix-secreting pericytes which destabilize the vasculature and create immune deserts. However, due to their inherent plasticity, proliferative tumor pericytes can be 'coerced' to switch back into a more quiescent and contractile state, a process which underpins durable tumor vessel normalization. Therapeutically, pericyte phenotype switching can be induced by targeting oncogenic, metabolic, or microtubule signaling pathways which induce Rho kinase activity. Thus, harnessing pericyte plasticity provides unique opportunities to synergize targeted anticancer therapies with immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PericytesNeoplasmsNeovascularization, PathologicHumansPhenotypeTumor MicroenvironmentAnimalsSignal TransductionCell PlasticityImmunotherapy

Stichwörter der Autor:innen

angiogenesisblood vessel normalizationcancerimmunotherapypericytes

Autor:innen und Institutionen

  • Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Australia.
  • Cancer Microenvironment Laboratory, Harry Perkins Institute of Medical Research, QEII Medical Centre and Centre for Medical Research, The University of Western Australia, Perth, Australia. Electronic address: ganss@perk…

Förderung

  • Cancer Australia
  • Cancer Council Western Australia
  • Eisai Canada
  • National Health and Medical Research Council
  • Worldwide Cancer Research

Zitieren

APA

He, B., & Ganss, R. (2025). Pericyte phenotype switching in cancer. Trends in Cancer, 11(9), 877-888. https://doi.org/10.1016/j.trecan.2025.06.005

Vancouver

He B, Ganss R. Pericyte phenotype switching in cancer. Trends in Cancer. 2025;11(9):877-888. doi:10.1016/j.trecan.2025.06.005

BibTeX
@article{He2025,
  author = {He, Bo and Ganss, Ruth},
  title = {Pericyte phenotype switching in cancer},
  journal = {Trends in Cancer},
  year = {2025},
  volume = {11},
  number = {9},
  pages = {877--888},
  doi = {10.1016/j.trecan.2025.06.005}
}
Kostenlos starten →